Mpox Africa Outbreak Declared No Longer Global Health Emergency
- The World Health Organization (WHO) announced on May 11, 2024, that the mpox outbreak, previously known as monkeypox, is no longer considered a global health emergency.
- Despite the lifted emergency status, the WHO emphasized that mpox remains a health concern, especially in Africa, where the virus is endemic.
- While cases have significantly decreased globally, the WHO highlighted that the outbreak continues to affect several African countries with limited resources.
mpox No Longer a Global Health Emergency, WHO Declares
Table of Contents
Declining Cases Led to shift in WHO Status
The World Health Organization (WHO) announced on May 11, 2024, that the mpox outbreak, previously known as monkeypox, is no longer considered a global health emergency. This declaration signifies a considerable decline in reported cases worldwide, prompting a reassessment of the international risk level.The initial global health emergency was declared on July 23, 2022, in response to a rapid increase in cases across multiple countries.
Despite the lifted emergency status, the WHO emphasized that mpox remains a health concern, especially in Africa, where the virus is endemic. the organization stressed the need for continued vigilance and sustained public health measures to prevent future outbreaks.
Disproportionate Impact in Africa
While cases have significantly decreased globally, the WHO highlighted that the outbreak continues to affect several African countries with limited resources. The continent accounts for the vast majority of reported deaths from mpox, underscoring the need for increased support and access to vaccines and treatments. According to the WHO, approximately 80% of all deaths attributed to mpox have occurred in Africa.
The WHO Director-General, Tedros Adhanom Ghebreyesus, acknowledged the progress made in controlling the outbreak but cautioned against complacency. He stated that the lifting of the emergency declaration does not mean the end of mpox, and sustained efforts are crucial to protect vulnerable populations.
Global Response and Vaccination Efforts
The global response to the mpox outbreak involved widespread vaccination campaigns, particularly in countries with high transmission rates. Vaccines developed for smallpox have proven effective against mpox,and their availability played a key role in curbing the spread of the virus. The Jynneos vaccine, specifically approved for mpox prevention, was deployed in several countries, including the United States and European nations.
The WHO continues to advocate for equitable access to vaccines and treatments, especially for African countries where the burden of the disease remains high. Strengthening surveillance systems and improving diagnostic capabilities are also essential components of the ongoing response.